SOLV MEXC RealStocks
Own real SOLV shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 08:56:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Solventum Corporation (SOLV) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $84.51, with a market capitalization of $15.14B and a P/E ratio of 97.05. Over the past 52 weeks, its price has ranged from $62.38 to $94.16. This page covers its latest market performance, valuation, price trends and company information.
$15.14B | |
$84.51 | |
$84.51 | |
$84.51 | |
$89.08 | |
-- | |
1.05M | |
97.05 | |
$94.16 | |
$62.38 | |
-- | |
-- |
Solventum Corporation (SOLV) last closed at $84.51 as of 2026-11-16 08:05:00, unchanged from the previous close of $89.08.
During the latest regular trading session, SOLV traded between $84.51 and $84.51, with a volume of 0.00 shares. The closing price was -- and near the upper end of its 52-week range.
Over the past seven days, Solventum Corporation (SOLV) moved from $87.18 to $84.51, representing a decline of 3.06% ($2.67).
The stock traded between $84.51 and $93.10 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 1.46 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 69.6%
SOLV is currently trading at $84.51, placing it 69.6% of the way from its 52-week low of $62.38 to its 52-week high of $94.16. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and infection prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 20,000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Solventum Corporation (SOLV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SOLV, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SOLV shares and USD.
SOLV Shares to USD
1.00 SOLV shares = 84.51 USD
Calculations are estimates based on the latest available price and are for reference only.